The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
PreviousPrevious
Volume 296:1203-1210 May 26, 1977 Number 21
NextNext

When may research be stopped?
C Cohen

 Sign up for free e-toc
 

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
Abstract

The prohibition of research with recombinant DNA must rely upon some argument that both establishes a principle, applicable to research in any sphere, identifying kinds of defect or hazard that are intolerable, and shows that recombinant DNA research is intolerably defective or hazardous in the ways specified by that principle. No such argument succeeds. Of arguments proposed to defend prohibition it may be fairly said either that the major premise (the principle of prohibition) is false, or when sound principles are put forward, that the minor premise (specifying recombinant DNA research as defective or hazardous in the ways called for) is far from established. There is no valid practical syllogism, having true premises, whose conclusion is that research with recombinant DNA should be stopped.

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.